CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- S-3 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 424B4 Offering Prospectus
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- 424B4 Offering Prospectus
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
Page 2 of 3 · 42 filings